TwinStrand Biosciences TwinStrand Biosciences Raises $50M in Series B Round The company is commercializing an error-reducing duplex sequencing technology that can identify ultra-low frequency genomic variants. TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications Premium Since the commercial launch of its technology last year, the firm has been validating it in studies with academic groups and pharmaceutical companies. Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences TwinStrand's duplex sequencing correction technology can detect ultra-low frequency DNA mutations that are otherwise often obscured by technical noise. TwinStrand Biosciences Closes $16M Series A Round The University of Washington spinout will use the funding to commercialize duplex sequencing technology to detect low-frequency DNA mutations. TwinStrand Targets Toxicity Testing, Cancer Diagnostics for Sequencing Error Correction Tech Premium The firm is preparing to launch its first kits and has identified cancer detection and monitoring as well as genotoxicity testing as initial applications. Aug 21, 2012 UW Team Says 'Duplex Sequencing' Method Offers Millions-Fold Improvement in Error Rate Premium Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.